Georgia Erbez
2020 - Harpoon Therapeutics
In 2020, Georgia Erbez earned a total compensation of $1M as Chief Financial Officer at Harpoon Therapeutics, a 90% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $156,000 |
|---|---|
| Option Awards | $468,734 |
| Salary | $390,000 |
| Other | $8,550 |
| Total | $1,023,284 |
Erbez received $468.7K in option awards, accounting for 46% of the total pay in 2020.
Erbez also received $156K in non-equity incentive plan, $390K in salary and $8.6K in other compensation.
Rankings
In 2020, Georgia Erbez's compensation ranked 8,544th out of 13,090 executives tracked by ExecPay. In other words, Erbez earned more than 34.7% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 8,544 out of 13,090 | 35th |
Division Manufacturing | 3,636 out of 5,624 | 35th |
Major group Chemicals And Allied Products | 1,470 out of 2,257 | 35th |
Industry group Drugs | 1,281 out of 1,957 | 35th |
Industry Biological Products, Except Diagnostic Substances | 300 out of 411 | 27th |
Source: SEC filing on March 24, 2021.
Erbez's colleagues
We found two more compensation records of executives who worked with Georgia Erbez at Harpoon Therapeutics in 2020.